Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
922 | 2 | WARFARIN//DABIGATRAN//RIVAROXABAN | 11329 |
2249 | 1 | CYP2C9//VKORC1//WARFARIN | 2344 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYP2C9 | authKW | 3880608 | 20% | 63% | 460 |
2 | VKORC1 | authKW | 2931895 | 11% | 82% | 265 |
3 | WARFARIN | authKW | 2125565 | 34% | 20% | 791 |
4 | ACENOCOUMAROL | authKW | 716618 | 4% | 52% | 103 |
5 | CYP4F2 | authKW | 565286 | 2% | 73% | 58 |
6 | CYTOCHROME P450 2C9 | authKW | 306717 | 2% | 62% | 37 |
7 | DOSING ALGORITHM | authKW | 274864 | 1% | 66% | 31 |
8 | PHENPROCOUMON | authKW | 248378 | 2% | 35% | 53 |
9 | PHARMACOGENETICS | authKW | 215445 | 11% | 6% | 265 |
10 | CYP2C9 POLYMORPHISM | authKW | 177931 | 1% | 88% | 15 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 18629 | 52% | 0% | 1212 |
2 | Hematology | 4250 | 14% | 0% | 317 |
3 | Peripheral Vascular Diseases | 2229 | 10% | 0% | 226 |
4 | Medical Laboratory Technology | 1036 | 4% | 0% | 87 |
5 | Medicine, General & Internal | 860 | 10% | 0% | 242 |
6 | Genetics & Heredity | 315 | 6% | 0% | 146 |
7 | Toxicology | 267 | 4% | 0% | 93 |
8 | Cardiac & Cardiovascular System | 130 | 4% | 0% | 100 |
9 | Medicine, Research & Experimental | 42 | 3% | 0% | 67 |
10 | Chemistry, Analytical | 40 | 3% | 0% | 80 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | METHODIST INPATIENT PHYS | 40332 | 0% | 100% | 3 |
2 | PHARMACOTHER Y TRANSLAT | 27685 | 1% | 8% | 25 |
3 | ANTICOAGULAT | 26888 | 0% | 100% | 2 |
4 | ATHEROTHROMBOSISMED CLIN 1 | 26888 | 0% | 100% | 2 |
5 | BROWNSTONE OUTPATIENT CLIN | 26888 | 0% | 100% | 2 |
6 | CLIN PHARM CLIN CHEM HAEMATOL | 26888 | 0% | 100% | 2 |
7 | MULTIDISCIPLINARY MOL BIOL DIAGNOST | 26888 | 0% | 100% | 2 |
8 | PHYSIOPATHOL GENET CARDIOVASC | 26888 | 0% | 100% | 2 |
9 | QUAL PATIENTSAFETY | 26888 | 0% | 100% | 2 |
10 | DRUG SAFETY UNIT | 25071 | 1% | 13% | 14 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACOGENOMICS | 61971 | 4% | 5% | 92 |
2 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 24933 | 4% | 2% | 105 |
3 | PHARMACOGENETICS | 21564 | 2% | 4% | 39 |
4 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 17936 | 4% | 1% | 98 |
5 | PHARMACOGENETICS AND GENOMICS | 16604 | 2% | 3% | 38 |
6 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 11599 | 2% | 2% | 41 |
7 | PHARMACOGENOMICS JOURNAL | 11587 | 1% | 3% | 27 |
8 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 10873 | 3% | 1% | 82 |
9 | PHARMACOTHERAPY | 8736 | 2% | 1% | 55 |
10 | PERSONALIZED MEDICINE | 8677 | 1% | 3% | 19 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP2C9 | 3880608 | 20% | 63% | 460 | Search CYP2C9 | Search CYP2C9 |
2 | VKORC1 | 2931895 | 11% | 82% | 265 | Search VKORC1 | Search VKORC1 |
3 | WARFARIN | 2125565 | 34% | 20% | 791 | Search WARFARIN | Search WARFARIN |
4 | ACENOCOUMAROL | 716618 | 4% | 52% | 103 | Search ACENOCOUMAROL | Search ACENOCOUMAROL |
5 | CYP4F2 | 565286 | 2% | 73% | 58 | Search CYP4F2 | Search CYP4F2 |
6 | CYTOCHROME P450 2C9 | 306717 | 2% | 62% | 37 | Search CYTOCHROME+P450+2C9 | Search CYTOCHROME+P450+2C9 |
7 | DOSING ALGORITHM | 274864 | 1% | 66% | 31 | Search DOSING+ALGORITHM | Search DOSING+ALGORITHM |
8 | PHENPROCOUMON | 248378 | 2% | 35% | 53 | Search PHENPROCOUMON | Search PHENPROCOUMON |
9 | PHARMACOGENETICS | 215445 | 11% | 6% | 265 | Search PHARMACOGENETICS | Search PHARMACOGENETICS |
10 | CYP2C9 POLYMORPHISM | 177931 | 1% | 88% | 15 | Search CYP2C9+POLYMORPHISM | Search CYP2C9+POLYMORPHISM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |